Ridgeback Capital
New York City, New Yorkridgebackcap.com
Overview
Ridgeback Capital is an actively managed private investment company that specializes in both securities trading and long-term private investment, with a specialized focus on investing in life science companies . The firm invests in private and public companies dedicated to the development of life-saving and life-changing therapies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hinge Bio | Jan 2025 | Series A | Co-investor |
| LENZ Therapeutics | Jul 2024 | PIPE | Lead |
| LENZ Therapeutics | Jul 2024 | PIPE | Lead |
| Crisp | Feb 2022 | Series B | Co-investor |
| Freenome | Dec 2021 | Series D | - |
Key People
Wayne Holman
Founder CEO
Jeffrey Long-McGie
Managing Director Analyst (Private Investments)
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
